factual
Subcutaneous second generation improves patient experience
Argenx's first-generation drug was intravenous, requiring a roughly one-hour hospital infusion, while the second-generation subcutaneous injection changes the treatment experience for patients.
factualpending
Speaker
JuliaEvidence Quote
“the second generation of the drug is subcutaneous. So it's an injection in a muscle, which completely changes the experience of the treatment.”
Created: 11/17/2026, 3:39:21 AM
Your notes
Loading notes...